These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11345717)

  • 41. In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement.
    Kimura T; Sako K; Gotoh T; Tanaka K; Tanaka T
    NMR Biomed; 2001 Oct; 14(6):339-49. PubMed ID: 11599032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Malignancy of brain tumors evaluated by proton magnetic resonance spectroscopy (1H-MRS) in vitro.
    Czernicki Z; Horsztyński D; Jankowski W; Grieb P; Walecki J
    Acta Neurochir Suppl; 2000; 76():17-20. PubMed ID: 11449999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integration of biochemical images of a tumor into frameless stereotaxy achieved using a magnetic resonance imaging/magnetic resonance spectroscopy hybrid data set.
    Stadlbauer A; Moser E; Gruber S; Nimsky C; Fahlbusch R; Ganslandt O
    J Neurosurg; 2004 Aug; 101(2):287-94. PubMed ID: 15309921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo proton magnetic resonance spectroscopy of brain tumors.
    Fountas KN; Kapsalaki EZ; Gotsis SD; Kapsalakis JZ; Smisson HF; Johnston KW; Robinson JS; Papadakis N
    Stereotact Funct Neurosurg; 2000; 74(2):83-94. PubMed ID: 11251398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dysembryoplastic neuroepithelial tumors: proton MR spectroscopy, diffusion and perfusion characteristics.
    Bulakbasi N; Kocaoglu M; Sanal TH; Tayfun C
    Neuroradiology; 2007 Oct; 49(10):805-12. PubMed ID: 17632714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients.
    Sharma R; Venkatasubramanian PN; Bárány M; Davis JM
    Schizophr Res; 1992 Oct; 8(1):43-9. PubMed ID: 1329928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
    Zhou GF; Wang XY; Gong CG; Liu F; Wang RW
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of basal ganglia magnetic resonance spectroscopy with Apgar score in perinatal asphyxia.
    Pavlakis SG; Kingsley PB; Harper R; Buckwald S; Spinazzola R; Frank Y; Prohovnik I
    Arch Neurol; 1999 Dec; 56(12):1476-81. PubMed ID: 10593302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging.
    Boesch SM; Wolf C; Seppi K; Felber S; Wenning GK; Schocke M
    J Magn Reson Imaging; 2007 Mar; 25(3):564-9. PubMed ID: 17326083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma.
    Chan AA; Lau A; Pirzkall A; Chang SM; Verhey LJ; Larson D; McDermott MW; Dillon WP; Nelson SJ
    J Neurosurg; 2004 Sep; 101(3):467-75. PubMed ID: 15352605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Temporal and regional changes during focal ischemia in rat brain studied by proton spectroscopic imaging and quantitative diffusion NMR imaging.
    Dreher W; Kühn B; Gyngell ML; Busch E; Niendorf T; Hossmann KA; Leibfritz D
    Magn Reson Med; 1998 Jun; 39(6):878-88. PubMed ID: 9621911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-invasive characterization of brain tumor by in-vivo proton magnetic resonance spectroscopy.
    Harada M; Tanouchi M; Nishitani H; Miyoshi H; Bandou K; Kannuki S
    Jpn J Cancer Res; 1995 Mar; 86(3):329-32. PubMed ID: 7744704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
    Plotkin M; Eisenacher J; Bruhn H; Wurm R; Michel R; Stockhammer F; Feussner A; Dudeck O; Wust P; Felix R; Amthauer H
    J Neurooncol; 2004 Oct; 70(1):49-58. PubMed ID: 15527107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
    Zacharia TT; Law M; Naidich TP; Leeds NE
    J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of a stereotactic headframe assembly on proton magnetic resonance spectroscopy.
    Campeau NG; Wood CP; Erickson BJ; Jack CR; Felmlee JP
    Stereotact Funct Neurosurg; 1998; 71(4):190-202. PubMed ID: 10461105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 1H chemical shift imaging of the human brain at age 60-90 years reveals metabolic differences between women and men.
    Sijens PE; Oudkerk M; de Leeuw FE; de Groot JC; Achten E; Heijboer R; Hofman A; Breteler MM
    Magn Reson Med; 1999 Jul; 42(1):24-31. PubMed ID: 10398946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.